Skip to main content
    C

    CME Group Inc (CME)

    Official site

    FINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ

    $311.56
    -7.81 (-2.45%)

    Market Cap: $114.31B

    Last updated: Nov 17, 2026 at 4:40 PM ET

    CME Group Inc (CME) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    CME Group (CME) has a market cap of $114.31B and an enterprise value of $115.54B. It kept 63.33% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 1.07% above the market cap, as debt exceeds cash.

    Market Cap$114.31B
    Enterprise Value$115.54B
    Latest price (Nov 17, 2026)$311.56

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 11, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateOct 21, 2026
    Next Ex-Dividend DateDec 11, 2026
    Next Payment DateDec 30, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.74% in the quarter ended Sep 30, 2026 and shrank 0.19% a year over 2 years.

    Shares Outstanding358.02M
    Shares Change (YoY)-0.46%
    Shares Change (QoQ)-0.74%
    Share Count Growth (2Y CAGR)-0.19%

    Valuation Ratios

    Sales and book value multiples are 16.0x and 4.2x. Its year-end P/E ranged from 21.1x to 34.1x from 2016 to 2025.

    P/E Ratio25.7x
    Forward P/E24.9x
    P/S Ratio16.0x
    Forward P/S16.1x
    P/B Ratio4.2x
    P/FCF Ratio25.7x
    P/OCF Ratio25.8x
    PEG Ratio3.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 26.0x free cash flow.

    EV / Earnings26.2x
    EV / Sales16.6x
    EV / FCF26.0x

    Price Statistics

    The stock is up 13.05% over 52 weeks and trades 8.39% above its 50-day average.

    Beta (1Y)-0.29
    52-Week Change+13.05%
    1-Month Change+6.14%
    3-Month Change+17.27%
    6-Month Change+4.05%
    5-Year Change+37.45%
    10-Year Change+202.84%
    Total Return (1Y)+17.15%
    Total Return (3Y CAGR)+18.21%
    Total Return (5Y CAGR)+11.09%
    Return vs SPY (1Y)+3.82%
    Max Drawdown (1Y)-31.39%
    Max Drawdown (3Y)-31.39%
    Sharpe Ratio (1Y)0.58
    Correlation with SPY (1Y)-0.16
    50-Day Average$287.44
    200-Day Average$279.68
    52-Week Range$217.29 to $321.39
    RSI (14 Days)60.9
    Average Volume (20 Days)1.89M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.02x current liabilities, and total debt is 0.13x shareholder equity.

    Current Ratio1.02x
    Quick Ratio1.02x
    Debt / Equity0.13x
    Debt / FCF0.79x
    Interest Coverage1.69x

    Returns and Efficiency

    Return on invested capital is -1.17% over the last 12 months, against a 5-year average of 1.31%.

    Return on Equity (ROE)16.63%
    Return on Assets (ROA)2.30%
    Return on Invested Capital (ROIC)-1.17%
    ROE (5Y Average)11.84%
    ROA (5Y Average)2.00%
    ROIC (5Y Average)1.31%
    Asset Turnover0.04x
    Receivables Turnover9.05x

    Taxes

    Income tax took 23.49% of pretax income over the last 12 months.

    Income Tax (TTM)$1.36B
    Effective Tax Rate23.49%

    Scores

    CME has an Altman Z-Score of 0.50, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score0.50
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $6.97B over the last 12 months is up 8.99% from the 12 months before.

    Revenue$6.97B
    Revenue Growth (YoY)+8.99%
    Gross Profit$6.04B
    Operating Income$4.58B
    Pretax Income$5.77B
    Net Income$4.42B
    Reported EPS (TTM)$12.14

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 13.83% of the $192.09B in total assets.

    Cash and Equivalents$2.20B
    Total Debt$3.43B
    Net Debt$1.23B
    Net Debt Per Share$3.43
    Working Capital$3.03B
    Shareholder Equity$26.56B
    Book Value Per Share$74.19
    Tangible Book Value-$3.56B
    Total Assets$192.09B
    Total Liabilities$165.53B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $93.70M of capital spending, operating cash flow left $4.33B of free cash flow.

    Operating Cash Flow$4.43B
    Capital Expenditures$93.70M
    Free Cash Flow$4.33B
    FCF Per Share$12.05
    Depreciation and Amortization$333.30M
    Dividends Paid$4.09B
    Share Repurchases$2.02B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 65.66%, against a 5-year average of 61.41%.

    Gross Margin86.63%
    Operating Margin65.66%
    Pretax Margin82.78%
    Net Margin63.33%
    FCF Margin62.15%
    Gross Margin (5Y Average)84.90%
    Operating Margin (5Y Average)61.41%
    Net Margin (5Y Average)57.53%

    Growth

    Revenue grew 9.11% a year over 3 years, and EPS 12.00% a year.

    Revenue Growth (3Y CAGR)+9.11%
    Revenue Growth (5Y CAGR)+5.95%
    EPS Growth (3Y CAGR)+12.00%
    EPS Growth (5Y CAGR)+10.74%
    FCF Growth (3Y CAGR)+12.23%
    FCF Growth (5Y CAGR)+10.74%
    Operating Income Growth (3Y CAGR)+11.93%
    Book Value Per Share Growth (2Y CAGR)+3.58%

    Revenue and profit by year

    Dividends and Yields

    CME pays out 31.14% of earnings as dividends.

    Dividend Per Share (Annual)$5.20
    Dividend Yield1.67%
    Dividend Growth (3Y CAGR)+7.72%
    Dividend Growth (5Y CAGR)+8.02%
    Payout Ratio31.14%
    FCF Payout Ratio94.29%
    Earnings Yield3.89%
    FCF Yield3.88%
    Buyback Yield1.81%
    Shareholder Yield5.47%

    Full dividend history

    Stock Splits

    The last split was a 5-for-1 forward split on Jul 23, 2012.

    Last Split DateJul 23, 2012
    Split TypeForward split
    Split Ratio5:1

    Peer Position

    Against 10 similar companies, CME has the 6th highest P/E.

    P/E Ratio25.7x vs 25.1x median
    P/S Ratio16.0x vs 6.1x median
    ROIC-1.17% vs 14.27% median
    Revenue Growth (Trailing 4 Quarters, YoY)+8.99% vs +9.60% median
    Dividend Yield1.67% vs 1.05% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.02% and EPS growth at 8.70% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.02%
    EPS Growth Forecast (2Y CAGR)+8.70%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CME

    What is CME's market cap?

    CME Group has a market cap of $114.31B. Its enterprise value, which adds debt and subtracts cash, is $115.54B.

    What is CME's P/E ratio?

    CME Group has a trailing P/E ratio of 25.7x and a forward P/E of 24.9x.

    How many shares of CME are outstanding?

    CME Group has 358.02M shares outstanding. The count is down 0.46% from a year earlier.

    Does CME pay a dividend?

    Yes. CME Group pays $5.20 a share a year, a dividend yield of 1.67%.

    How much debt does CME have?

    CME Group has $3.43B of total debt and $2.20B of cash and equivalents, a net debt position of $1.23B.